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INTRODUCTION
The pathogenesis of meningitis is 
believed to involve microorganisms in the 
nasopharynx crossing mucosal surfaces 
into the bloodstream from where they gain 
access to the subarachnoid space1–8 but 
what triggers this transmission is less clear. 
One significant risk factor is the presence 
of Neisseria meningitidis (the causative 
organism of meningococcal meningitis) in 
the nasopharynx9; carriage rates as high as 
24% have been identified in 19-year-olds.10,11 
How is it that a commensal becomes a 
pathogen? Disturbance of the patient’s 
microbiome, the enormous numbers of 
commensal, symbiotic, and pathogenic 
microorganisms that colonise the human 
body, may be a plausible explanation.
In recent years a number of studies have 
begun to explore the role of the human 
microbiome — mainly those commensal 
bacteria inhabiting the gut — in maintaining 
health.12,13 The integrity of the microbiome 
may be disrupted by ingesting antimicrobials 
and there are suggestions that diseases as 
diverse as asthma and inflammatory bowel 
disease may have their pathogenesis in 
antimicrobial-induced harm, particularly 
in the early years of life.14,15 At its most 
extreme, seen commonly in intensive 
care units, antimicrobial use is associated 
with overwhelming infections by resistant 
organisms due in part to the removal of 
competition from less resistant bacteria in 
the patient’s gut. 
The role of excessive antimicrobial 
prescribing in provoking the emergence 
of resistant bacteria has now become a 
major concern16 but antimicrobials may 
also affect the microbiome in more subtle 
ways. It is possible that an antimicrobial 
prescription could, ironically in view of 
its traditional therapeutic role, increase 
meningitis risk either by damaging 
commensals in the nasopharynx resulting 
in decreased competitive inhibition of other 
organisms or by impairing the protective 
effect of the immune system. The present 
study aimed to investigate the possibility 
that antimicrobial overprescribing may be 
associated with increased risk of bacterial 
and viral meningitis. The study also explored 
a potential dose–response relationship 
between antimicrobial prescribing and risk 
of meningitis. Finally, the study assessed 
the possibility that the risk of meningitis 
may vary among antimicrobial drugs with 
broad and narrow spectrum of action.
METHOD
A case-control study was implemented in 
a large primary care database, the Clinical 
Practice Research Datalink (CPRD). CPRD 
currently contains medical records from 
685 general practices representing one of 
the world’s largest electronic databases of 
anonymised longitudinal data from primary 
care. The size, patients’ characteristics, 
and geographical distribution of the CPRD 
primary care practices are representative of 
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Background
Recent research into the role of the human 
microbiome in maintaining health has 
identified the potentially harmful impact of 
antimicrobials. 
Aim
The association with bacterial and viral 
meningitis following antimicrobial prescription 
during the previous year was investigated 
to determine whether antimicrobials have 
a deleterious effect on the nasopharyngeal 
microbiome.
Design and setting
A case-control study (1:4 cases to controls) 
was conducted examining the rate of previous 
antimicrobial exposure in cases of meningitis 
and in a matched control group. Data from a UK 
primary care clinical database were analysed 
using conditional logistic regression.
Results
A total of 7346 cases of meningitis were 
identified, 3307 (45%) viral, 1812 (25%) bacterial, 
and 2227 (30%) unspecified. The risks of viral 
(adjusted odds ratio [AOR] 2.45; 95% confidence 
interval [CI] = 2.24 to 2.68) or bacterial 
(AOR 1.98; 95% CI = 1.71 to 2.30) meningitis 
were both increased following antimicrobial 
prescription in the preceding year. Patients who 
received ≥4 antimicrobial prescriptions in the 
preceding year were at significantly increased 
risk of all types of meningitis (AOR 2.85; 
95% CI = 2.44 to 3.34), bacterial meningitis 
(AOR 3.06; 95% CI = 2.26 to 4.15) and viral 
meningitis (AOR 3.23; 95% CI = 2.55 to 4.08) 
compared to their matched controls.
Conclusion
There was an increased risk of meningitis 
following antimicrobial prescription in the 
previous year. It is possible that this increase 
was due to an effect of antimicrobials on the 
microbiome or reflected an increased general 
susceptibility to infections in these patients.
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the UK population. The database includes 
complete records of all drugs prescribed, 
clinical diagnoses, referral to consultants, 
hospitalisations, and investigation results 
during primary care consultations. All 
prescriptions are computer generated and 
are automatically part of the patient medical 
record. The data have been extensively 
validated for pharmacoepidemiological, 
clinical, and health service usage 
research.17–20 Tate and colleagues provide a 
detailed description of the CPRD. 21
Study population
Patients with a recorded diagnosis of 
meningitis between 1 January 1992 and 
31 March 2014 represented the cases. The 
index date was defined as the first date that 
a diagnosis of meningitis was recorded. 
Cases were individually matched with up to 
four randomly selected controls, on age, sex, 
family practice, and index date for meningitis 
(controls were given the index date of the 
meningitis diagnosis of their matched case). 
Data were extracted in January 2015.
Outcomes
Medical diagnostic codes were used 
to identify new diagnoses of meningitis 
including viral, meningococcal, other 
bacterial, and unspecified cases. 
Exposure
The exposure variable included any 
antimicrobial prescription in the 12 months 
preceding the diagnosis of meningitis; 
that is, between the baseline and the 
index date for meningitis. Information 
extracted included the name of the specific 
antimicrobial, the number of antimicrobial 
prescriptions during the follow-up period, 
and the time lag from drug prescription to 
meningitis index date. The risk of meningitis 
following prescription of narrow spectrum 
antimicrobials and of trimethoprim was 
also examined: the former could be less 
harmful to the microbiome and the latter, 
in targeting predominantly gram-negative 
urinary tract infections, may have less effect 
on the mainly gram-positive bacteria in the 
nasopharyngeal microbiome.
Confounders
Several variables associated with infection, 
meningitis risk, and other comorbidities, 
were included as covariates. These included 
matching variables (age, sex, index date, 
and practice); cardiovascular risk factors 
including cholesterol, body mass index 
(BMI), (<18.5, 18.5–24.9, 25.0–29.9, 30.0–
34.9, and ≥35 kg/m2), lifestyle factors 
including smoking (never, ex-smoker, 
and current smoker); alcohol (never, 
ex-drinker, and current drinker); C-reactive 
protein (CRP) levels; comorbidity including 
depression, cancer, renal disease, and 
chronic obstructive pulmonary disorders 
(COPD), cardiovascular diseases (including 
stroke, coronary heart diseases, and 
diabetes); and co-prescribing including 
use of antihypertensive drugs, statins, and 
diabetes treatment. For each confounder, 
the value closest to the study baseline and 
before an antimicrobial drug prescription 
was included. For patients without an 
antimicrobial drug prescription the value 
closest to the baseline was selected. Where 
the closest recorded value for lifestyle and 
cardiovascular risk factors was >5 years 
prior to the study baseline, a missing value 
was recorded.
Statistical analysis
Case-control studies are open to 
confounding as the apparent relationship 
between the exposure and disease may be 
mediated by some other factor. Therefore 
the relative exposure figures for important 
clinical factors, such as smoking22, that 
were available in the database and may 
be associated with both antimicrobial 
prescription and the occurrence of 
meningitis adjusted for. In addition, 
the relationship between antimicrobial 
consumption and subsequent meningitis 
may be confounded by indication such that, 
for example, those patients with prodromal 
meningitis and/or with a triggering infection 
could have consulted the GP and obtained 
an antimicrobial prescription in the days 
immediately before the emergence of 
clinically identifiable meningitis. For this 
reason the time between antimicrobial 
prescription and meningitis diagnosis was 
obtained from the database so that the 
data for the week immediately preceding 
diagnosis could be treated as possibly 
being contaminated by a triggering 
How this fits in
While there is considerable evidence 
that antimicrobials are effective against 
bacterial infection there is very limited 
evidence that they may trigger or increase 
the risk of subsequent infections. The 
finding that meningitis was more common 
following antimicrobial prescription could 
be the result of antimicrobials lowering 
the threshold for later infections whether 
through disturbance of the patient’s 
microbiome or through other mechanisms.  
This may be another reason for caution in 
prescribing antimicrobials.
British Journal of General Practice, April 2016  e229
infection. Identifying the time lag between 
antimicrobial prescription and meningitis 
diagnosis also allowed examination of the 
attenuation over time of any association 
between these two events. The association 
between antimicrobial use and the risk of 
viral meningitis were examined, as viruses 
may not have been directly affected by 
antimicrobials but their ecological niche in 
the nasopharynx may have been changed by 
antimicrobial use.23
Conditional logistic regression was used 
to determine the adjusted odds ratio (AORs) 
and 95% confidence intervals (CIs) for the 
association between antimicrobial exposure 
and risk of meningitis. Data on patients 
were extracted from the study baseline 
(the later of the start of the patient’s record 
in CPRD or 1 January 1992). Follow-up 
ended at the earliest of the meningitis 
index date, date of death, and the end 
of the CPRD record or 31 March 2014. 
Analyses estimated the associations 
between antimicrobial drugs and all-cause 
and subtypes of meningitis. Separate 
estimation models were conducted for 
the association of time lag, number of 
prescriptions (1, 2, 3, and ≥4), and drug 
type with the risk of meningitis. Analyses 
were adjusted for study confounders and 
for age, sex, family practice and index date 
for meningitis by matching. Data for lifestyle 
and vascular risk factors (such as, BMI, 
cholesterol, blood pressure, smoking, and 
drinking) were not available for all patients 
and multiple imputation was used to handle 
missing data. Following Rothman24 and 
Ridker et al  25 the analyses did not adjust for 
multiple comparisons. Data were analysed 
using Stata (version 12).
RESULTS
A total of 7346 cases of meningitis were 
identified during the study follow-up; 3307 
(45%) were recorded as viral, 1812 (25%) as 
bacterial, and 2227 (30%) were unspecified. 
Table 1 shows the baseline characteristics 
of study cases and controls. Overall, 
patients with meningitis were more likely to 
be diagnosed with COPD, depression, and 
renal diseases compared to their matched 
controls. 
Thirty-five per cent of patients with 
meningitis had received an antimicrobial 
prescription in the 12 months preceding 
their diagnosis compared with 20% of the 
control group (adjusted OR [AOR] 2.04, 
95% CI = 1.91 to 2.18, P <0.001). Patients 
with meningitis were more than four times 
more likely to have had an antimicrobial 
prescribed in the 7 days preceding the 
diagnosis (Figure 1). 
Figure 1 also shows the AORs for the risk 
of meningitis of the number of antimicrobial 
prescriptions recorded in the previous 
12 months for each patient divided into 
the four categories: 1; 2; 3; ≥4. Patients 
prescribed ≥4 antimicrobial prescriptions in 
the previous 12 months had a higher risk of 
meningitis (AOR 2.85, 95% CI = 2.44 to 3.04, 
P <0.001) compared to those prescribed 0 
(n = 1) or 1 (AOR 1.74, 95% CI = 1.62 to 1.88) 
antimicrobial. 
Table 1. Baseline characteristics for study cases and controls
 Cases (%), N = 7346 Controls (%), N = 29 384
Mean age (SD), years 22 (19) 22 (19)
Female 3773 (51) 15 092 (51)
Body mass indexa
 Underweight  156 (2) 730 (2)
 Healthy weight  1422 (19) 6113 (21)
 Overweight 795 (11) 3030 (10)
 Obese 488 (7) 1543 (5)
Smokinga   
 Never 1951 (27) 7658 (26)
 Past 417 (6) 1497 (5)
 Current 1037 (14) 3890 (13)
Alcohol usea
 Never 541 (7) 2431 (8)
 Past 46 (1) 112 (0)
 Current 2156 (29) 8593 (29)
Cholesterol, mg/dL  
 <5.15 337 (5) 1068 (4)
 5.15–6.19 229 (3) 749 (3)
 ≥6.20  129 (2) 426 (1)
C-reactive protein, mg/L  
 <1 25 (0) 69 (0)
 1–3 119 (2) 265 (1)
 >3 239 (3) 450 (2)
Morbidity
 Renal disease 262 (4) 615 (2)
 Coronary heart disease 75 (1) 238 (1)
 Stroke 61 (1) 69 (0)
 Diabetes mellitus 99 (1) 286 (1)
 Cancer 85 (1) 231 (1)
 Depression 945 (13) 2221 (8)
 Chronic obstructive pulmonary disease 1144 (16) 3.015 (10)
 Chronic inflammation 196 (3) 533 (2)
Therapy
 Lipid lowering  132 (2) 463 (2)
 Antihypertensive therapy 624 (8) 1658 (6)
 Diabetes mellitus treatment 95 (1) 270 (1)
aPercentages do not add up to 100% as for some patients the data were missing. SD = standard deviation.
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The relationships between antimicrobial 
prescriptions in the previous year (and 
various intervals within that year) and 
bacterial and viral meningitis are shown in 
Figures 2 and 3 respectively. The AORs for 
both types of meningitis were similar though 
the risk was higher for viral meningitis 
if antimicrobials had been prescribed in 
the 7 days immediately preceding diagnosis 
(AOR 7.84, 95% CI = 6.01 to 10.24, P <0.001) 
than for bacterial meningitis (AOR 2.64, 
95% CI = 1.86 to 3.76, P <0.001). There were 
no differences between bacterial and viral 
meningitis in terms of whether the patient 
had received a broad or narrow spectrum 
antimicrobial or trimethoprim prescribed 
for urinary tract infections.
DISCUSSION
Summary
In a large primary care-based population, a 
strong association was observed between 
meningitis and antimicrobial prescribing 
in the previous year. The association 
was particularly salient with respect to 
antimicrobials prescribed in the 7 days 
preceding the meningitis index date which 
may be the result of prodromal symptoms 
of meningitis being misdiagnosed, probably 
as upper respiratory tract infection; indeed, 
preceding infection/feeling unwell is a 
recognised risk factor.26 Even so, such a 
‘prophylactic’ antimicrobial prescription 
clearly did not have any effect on the 
subsequent meningitis. Assuming that 
the prodromal phase of meningitis was 
no longer than 1 week the association 
with antimicrobials prescribed in the year 
preceding the index date (and excluding 
the previous 7 days) is unlikely to have been 
confounded by indication.
The original hypothesis that antimicrobials 
may change the nasopharyngeal microbiome 
in such a way as to facilitate bacterial or viral 
meningitis has not been wholly supported 
by these findings as there was no evidence 
that the association between antimicrobials 
and meningitis attenuates over time as may 
be expected if the microbiome recovered 
during the year following a prescription. 
Nor were there reduced risks of meningitis 
following narrow spectrum antimicrobials 
and a urinary tract-targeted antimicrobial 
in the previous year, although there was 
a dose–response in that patients with ≥4 
antimicrobial prescriptions in the previous 
12 months had a stronger association with 
meningitis, particularly bacterial meningitis.
The possible role of antimicrobial damage 
to the microbiome in increasing the risk of 
viral meningitis would be more indirect. As 
there seems to be substantial colonisation 
of bacteria in the microbiome by viral 
commensals (bacteriophages), removal 
of the host bacteria for these viruses by 
antimicrobial prescription may expose the 
patient to greater risk of viral pathogen 
invasion.23,27,28 Alternatively, the association 
between antimicrobials and meningitis could 
reflect more generalised immunological 
suppression or infection susceptibility such 
as frailty in the patient lasting more than 
a year which led to presentation to the 
GP with a variety of infections, including 
meningitis, for which antimicrobials were 
prescribed. Indeed, there is evidence that 
patients with meningococcal disease are 
more likely to show serological evidence of 
recent influenza and respiratory syncytial 
viral infection.29,30 
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Figure 1. Association between risk of all-cause 
meningitis and antimicrobials prescription in the 
previous 12 months. UTI = urinary tract infection.
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Figure 2. Association between risk of bacterial 
meningitis and antimicrobials prescription in the 
previous 12 months. UTI = urinary tract infection.
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Strengths and limitations
The strength of this study lies mainly in the 
large number of meningitis cases used in 
the analysis and the likely reliability of the 
clinical diagnoses and drug prescriptions. 
The main weakness of this study lies in 
the difficulty of inferring causality from its 
case-control design as residual confounding 
due to unmeasured factors cannot be ruled 
out. For example, patients with greater 
general susceptibility to infections, including 
meningitis, may have presented to their GP 
more frequently during the previous year 
and received more antimicrobials. However, 
the study did adjust for several chronic 
diseases and related-biomarkers (such as, 
CRP), commonly used as indicators of frailty. 
Meningitis is a diagnosis made in 
secondary care, most commonly following 
a lumbar puncture; this diagnosis would 
then be transcribed into the GP electronic 
record. It is possible that some diagnoses 
did not get transcribed into the GP records 
and/or were transcribed without their 
specific causal organism being identified. 
These failures may only minimally impact 
the present findings. Antimicrobial 
prescriptions are known to be well recorded 
in the clinical database (although incidental 
prescriptions given elsewhere, such as 
in emergency departments or in walk-in 
centres would not be recorded) but there 
is no record of whether or not the patients 
took the prescribed drugs as indicated. Non-
adherence by patients, would, if anything, 
have led to an underestimate of the AORs 
associated with antimicrobial use.
Nearly 30% of cases of meningitis 
were recorded without reference to the 
specific causative agent. It is possible that 
correct attribution would alter the size of 
the estimates observed here, but less so 
the direction of association. The similarity 
between viral and bacterial meningitis in 
their association with previous prescriptions 
of antimicrobials makes it unlikely that this 
limitation has made an important difference 
to the observed relationships. A further 
weakness of this study is that it was not 
possible to determine the precise indication 
for the antimicrobial prescriptions recorded 
and so it cannot be investigated whether 
the association between these prescriptions 
and the diagnosis of meningitis is explained 
by the indication for the prescription or 
is independent of that indication. The 
lack of difference between the classes 
of antimicrobials examined and their 
association with meningitis would suggest 
that the indication was not important.
Comparison with existing literature
There is evidence that infections in patients 
who have received antimicrobials in the 
subsequent 6 months are more likely to be 
caused by resistant organisms31 possibly as 
a result of decolonisation of antimicrobial 
sensitive organisms within the microbiome. 
There is also emerging evidence that 
disruption of the microbiome in the first 
year of life has a long-term effect on the risk 
of diseases such as asthma.32
Implications for research and practice
While the exact mechanism for the 
association between antimicrobial 
prescription and subsequent meningitis 
cannot be determined by the case control 
design used in this study the size of that 
association merits further investigation. It 
also adds another reason for caution in 
antimicrobial prescribing in general practice 
to the existing concerns about antimicrobial 
resistance.
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